Yu-Jing Liang

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

Lin-Quan Tang, Dong-Ping Chen, Ling Guo et al. · The Lancet Oncology · 2018 · 150 citations

Medicine, Oncology, Radiation Oncology +14

Alpinia zerumbet Potentially Elevates High-Density Lipoprotein Cholesterol Level in Hamsters

Li-Yun Lin, Chiung-Chi Peng, Yu-Jing Liang et al. · Journal of Agricultural and Food Chemistry · 2008 · 45 citations

Life Sciences, Botany, Pharmacology +16

Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy

Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu et al. · BMC Cancer · 2019 · 44 citations · Full text

Medicine, Oncology, Chemotherapy +16

Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance

Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu et al. · Cancer Research and Treatment · 2019 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study

Qiuyan Chen, Lin‐Quan Tang, Na Liu et al. · Cancer Communications · 2018 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17